Niferex (Ferrous (Ii) Glycine Sulfate Complex)

Ferrous (II) Glycine Sulfate Complex, the active ingredient in Niferex, is an iron supplement presented as an oral formulation for systemic use. It is employed to prevent and treat iron deficiency and to support normal hemoglobin levels in individuals with low iron stores.

GNH USA supplies Niferex as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for global distribution. Customers benefit from reliable supply chains and responsive technical support.

Niferex, an oral iron supplement, is used to address conditions related to insufficient iron availability. Iron deficiency anemia: restores hemoglobin concentration and alleviates fatigue. Pregnancy‑associated iron deficiency: supports maternal iron stores and fetal development. Pediatric iron deficiency: promotes normal growth and cognitive development in children with low iron. Chronic kidney disease‑related anemia: contributes to iron repletion as part of anemia management. Heart failure‑related iron deficiency: improves exercise capacity and quality of life. Post‑surgical blood loss: aids recovery of iron stores after operative procedures.

Oral administration of ferrous iron may be associated with several adverse reactions, ranging from mild gastrointestinal symptoms to rare serious events. Common Side Effects: - Nausea: mild queasiness often occurring after the dose. - Constipation or diarrhea: changes in bowel habits are frequently reported. - Abdominal discomfort: cramping or pain in the stomach region. - Darkened stools: harmless discoloration of feces due to iron. Serious or Rare Side Effects: - Severe allergic reaction: hives, swelling, or difficulty breathing requiring immediate medical attention. - Iron overload: signs include fatigue, joint pain, or organ dysfunction, typically with excessive dosing. - Hypotension: sudden drop in blood pressure may occur, especially if taken on an empty stomach.

When using Niferex, certain precautions help minimize risks and ensure optimal efficacy. Assess iron status: confirm deficiency with laboratory tests before initiating therapy. Monitor hemoglobin: periodic blood counts are recommended to track response. Take with food: ingestion with meals reduces gastrointestinal irritation. Avoid concurrent antacids: calcium or magnesium‑containing products can impair iron absorption. Use in children under medical supervision: dosage must be individualized by a healthcare professional. Store at ambient temperature: keep below 25°C in the original container, protect from moisture and direct sunlight.

Ferrous (II) Glycine Sulfate Complex can affect the absorption or activity of several other medicines. Major Interactions (Avoid): - Tetracycline antibiotics: chelation reduces effectiveness of both agents. - Fluoroquinolones: concurrent use markedly decreases antibiotic absorption. - Levothyroxine: iron interferes with thyroid hormone uptake, requiring separation of dosing. Moderate Interactions (Monitor Closely): - Proton pump inhibitors: reduced gastric acidity may lower iron absorption. - Calcium supplements or dairy products: can diminish iron uptake if taken together. - Antacids containing aluminum or magnesium: may modestly impair iron absorption.